Safety of 6-week Neonatal Triple-combination Antiretroviral Postexposure Prophylaxis in High-risk HIV-exposed Infants
© 2019 Pediatric Infectious Disease Journal. All rights reserved. Background: Combination antiretroviral drug regimens are increasingly preferred for neonatal postexposure prophylaxis (PEP) among HIV-exposed infants with high-risk of transmission. We evaluated the adverse events associated with the...
محفوظ في:
المؤلفون الرئيسيون: | Suvaporn Anugulruengkitt, Piyarat Suntarattiwong, Pradthana Ounchanum, Ussanee Srirompotong, Watsamon Jantarabenjakul, Jiratchaya Sophonphan, Sunti Punnahitanon, Chitsanu Pancharoen, Tim R. Cressey, Kulkanya Chokephaibulkit, Thanyawee Puthanakit |
---|---|
التنسيق: | دورية |
منشور في: |
2020
|
الموضوعات: | |
الوصول للمادة أونلاين: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85072791175&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/67965 |
الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Safety of 6-week Neonatal Triple-combination Antiretroviral Postexposure Prophylaxis in High-risk HIV-exposed Infants
بواسطة: Suvaporn Anugulruengkitt, وآخرون
منشور في: (2020) -
Nevirapine Concentrations During the First Month of Life and Maternal Efavirenz Washout in High-Risk HIV-Exposed Infants Receiving Triple Antiretroviral Prophylaxis
بواسطة: Suvaporn Anugulruengkitt, وآخرون
منشور في: (2019) -
Nevirapine concentrations during the first month of life and maternal efavirenz washout in high-risk hiv-exposed infants receiving triple antiretroviral prophylaxis
بواسطة: Suvaporn Anugulruengkitt, وآخرون
منشور في: (2020) -
Immunogenicity of a Japanese encephalitis chimeric virus vaccine as a booster dose after primary vaccination with SA14-14-2 vaccine in Thai children
بواسطة: Pakpoom Janewongwirot, وآخرون
منشور في: (2018) -
Pharmacokinetics of rilpivirine and 24-week outcomes after switching from efavirenz in virologically suppressed HIV-1-infected adolescents
بواسطة: Watsamon Jantarabenjakul, وآخرون
منشور في: (2018)